Takeda Pharmaceutical Company Limited (TAK) Stock Price

18.46 ▲ +0.09 (+0.49%)
Open: 18.37 Vol: 3.09M Day's range: 18.36 - 18.50 Feb 13, 16:00 EST
IEX quote, 15 minutes delayed during trading hours. Login or Signup to see real-time data
Free Stock Screener
Loading chart ...
TAK Technical Analysis
5 mins 30 mins Hourly Daily Weekly
BUY BUY BUY BUY BUY
  5 mins 30 mins Hourly Daily Weekly
MA5 18.42▲ 18.41▲ 18.42▲ 18.19▲ 17.21▲
MA10 18.41▲ 18.41▲ 18.40▲ 17.93▲ 16.28▲
MA20 18.41▲ 18.38▲ 18.35▲ 17.23▲ 15.17▲
MA50 18.41▲ 18.28▲ 18.08▲ 16.03▲ 14.98▲
MA100 18.40▲ 18.05▲ 17.64▲ 15.09▲ 14.34▲
MA200 18.35▲ 17.55▲ 16.86▲ 14.96▲ 14.60▲
  5 mins 30 mins Hourly Daily Weekly
MACD 0.006▲ -0.005▼ -0.008▼ 0.069▲ 0.398▲
RSI 73.028▲ 63.690▲ 69.760▲ 79.838▲ 77.841▲
STOCH 79.040     38.637     68.415     93.047▲ 95.204▲
WILL %R -8.696▲ -5.882▲ -3.846▲ -2.139▲ -0.810▲
CCI 380.952▲ 134.058▲ 123.973▲ 119.257▲ 157.161▲
Latest Filters Detected On TAK
▲ RSI&STOCH $TAK Overbought RSI + Stochastic Set Alert
BBANDS $TAK Bollinger Bands Expanding Set Alert
▲ BREAK $TAK Price Breaks 60 Days High Set Alert
▲ BREAK $TAK Price Breaks 30 Days High Set Alert
▲ BREAK $TAK Price Breaks 20 Days High Set Alert
▲ BREAK $TAK Price Breaks 10 Days High Set Alert
Takeda Pharmaceutical Company Limited News
U.S. Food and Drug Administration Accepts New Drug Application and Grants Priority Review for Takeda’s Oveporexton (TAK-861) as a Potential First-in-Class Therapy for ...
Tuesday, February 10, 2026 09:34 AM
Takeda (TSE:4502/NYSE:TAK) today announced that the U.S. Food and Drug Administration (FDA) accepted its New Drug Application (NDA) and granted Priority Review for oveporexton (TAK-861) for the ...
Takeda Taps AI Startup Iambic In $1.7 Billion+ Deal To Speed Up Drug Discovery
Monday, February 09, 2026 09:59 AM
AI startup Iambic on Monday announced a multi-year technology and discovery collaboration agreement with Takeda Pharmaceutical Company Limited TAK. The Japanese drug maker will use Iambic's AI drug ...
Is Takeda Pharmaceutical Company Limited (TAK) One of the Best Healthcare Stocks to Buy for 2026?
Saturday, January 31, 2026 06:36 AM
Takeda Pharmaceutical Company Limited (NYSE:TAK) is one of the best healthcare stocks to buy for 2026. Takeda Pharmaceutical Company Limited (NYSE:TAK) reported Q3 FY2025 results on January 29, 2026, ...
TAK historical stock data
date open high low close volume
13/02/26 18.37 18.50 18.36 18.46 3,086,991
12/02/26 18.30 18.447 18.23 18.37 2,820,191
11/02/26 18.20 18.30 18.12 18.28 1,815,342
10/02/26 18.00 18.16 17.99 18.10 2,128,380
09/02/26 17.71 17.79 17.58 17.73 2,232,030
06/02/26 17.82 17.985 17.70 17.89 3,024,037
05/02/26 17.82 17.935 17.755 17.80 2,679,934
04/02/26 17.63 17.83 17.63 17.74 2,499,800
03/02/26 17.34 17.535 17.34 17.43 3,932,678
02/02/26 17.21 17.545 17.21 17.49 4,201,277
Quote Details
52wk Low:12.99
52wk High:18.50
Vol:3.09M
Avg Vol(3m):49.3M
1Y Chng:+24.48%
1M Chng:+18.18%
Add to Watch List
More Information
Index N/A
Market Cap. 58.03B